Sanofi SA (SAN)

Industry Drug Manufacturers - General


This stock can be held in an Investment ISA and an Investment Account
Sell

€73.80

Buy

€74.50

arrow-down€-0.20 (-0.27%)

Prices updated at 22 Sep 2026, 16:35 CEST
| Prices minimum 15 mins delay
|
Prices in EUR

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immu ...

Most recent dividend payment

4.120
Cash Dividend
05 May 2026
29 Jan 2026
06 May 2026
07 May 2026

Total dividend yield

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20264.1200-
20253.92000.04
20243.76000.06
20233.56000.07
20223.33000.04
20213.20000.02
20203.15000.03
20193.07000.01
20183.03000.02
20172.96000.01

Total dividend yield data table

Dividend yield (%)Buyback yield (%)
20265.36-
20254.743.81
20244.010.30
20233.970.29
20223.710.35
20213.610.37
20204.000.22
20193.430.15
20184.001.01
20174.123.12

Dividend per share

% of earnings paid to shareholders

Dividend per share data table

YearDividend per share
20264.1200
20253.9200
20243.7600
20233.5600
20223.3300
20213.2000
20203.1500
20193.0700
20183.0300
20172.9600

% of earnings paid to shareholders data table

YearPayout ratio (%)
2026127.55
202574.81
2024104.74
202349.31
202265.33
202165.62
202035.59
2019121.60
201894.13
201781.89
Latest Financial Report as of 21 Sep 2026
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser.

© Copyright 2026 Morningstar. All rights reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

The ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.